Objectives. This study sought to determine whether the location of coronary spastic activity may change over time in patients with persistent variant angina.
Although many clinical studies (4, 6, 8, 9, 15, 21) have shown that coronary spasm frequently occurs at sites of advanced atherosclerosis, Conti et al. (7) suggested that the presence of significant atherosclerosis may reduce the role of vasospasm in ischemic attacks. To determine the long-term role of vasospastic activity and its variation in location, we repeated ergonovine provocation tests in patients without advanced atherosclerosis but with persistent symptoms of variant angina at an average interval of 43 months apart, using a computer-based quantitative coronary angiographic analysis system (CAAS II).
Methods
Criteria of vasospastic angina. The following criteria of vasospastic angina were used: 1) chest pain at rest associated with ST segment changes >0.2 mV on the ECG; 2) pain relief immediately after administration of nitroglycerin; 3) no subsequent evidence of myocardial infarction; 4) ergonovineprovoked coronary spasm associated with chest pain and ischemic ECG changes. Coronary spasm was defined as 1) a transient total or nearly total occlusion reversible with isosorbide dinitrate, or 2) a transient, significant (>50%) narrowing reversible with isosorbide dinitrate in normal or nearly normal segments (24) (25) (26) . We used the ergonovine provocation test because it has been found (27) (28) (29) to have a high sensitivity and specificity for, and short-term reproducibility of, spontaneous anginal attacks in patients with vasospastic angina. Follow-up angiography and provocation testing were performed to estimate the progression of atherosclerosis as well as to determine the location of vasospastic activity and to provide information on the necessity to continue long-term medication.
Study patients. Because the purpose of the present study was to examine the role of pure vasospasm in ischemic attacks during long-term follow-up, we excluded patients with significant atherosclerosis (>50% diameter stenosis after administration of isosorbide dinitrate). The study group was selected from a total of 50 patients with variant angina who had undergone long-term angiographic and ergonovine provocation follow-up. Of the 50 patients who had chest pain at rest with ischemic ST segment changes at the time of the initial angiographic study, vasospastic anginal symptoms were persistent during the follow-up period in 34. In the remaining 16 patients, symptoms of vasospastic angina resolved during follow-up, and these 16 patients were excluded from the study. Of the former 34 patients, 5 who developed significant, fixed stenosis (>50% diameter stenosis after administration of isosorbide dinitrate) during follow-up were excluded from the study. Of the remaining 29 patients, 13 had persistent symptoms of vasospastic angina with ischemic ST segment changes during the follow-up period, and vasospasm was reproduced at the same coronary segment at the follow-up angiogram (group 1 ); 16 patients had persistent symptoms of vasospastic angina with ischemic ST segment changes during the follow-up period, and vasospasm occurred in different vessels at follow-up (group 2).
Isehemic episode during follow-up, Vasospastic anginal activity was assessed by anginal symptoms, 12-lead ECG monitoring during anginal attacks and ambulatory in-hospital ECG monitoring or Holter monitoring out of hospital in all patients. All 29 patients had intermittent chest pain with ST segment changes at the time of the initial angiographic study (Table 1) . These attacks were frequently observed over a period of a few days to several weeks (so-caUed hot phases of the disease [21] ). The medication, combined with a calcium antagonist (diltiazem) and sustained-release isosorbide dinitrate (Table 2) , was effective and reduced the frequency of ischemic attacks in both groups; however, vasospastic angina persisted throughout the follow-up period. Over the follow-up period, 22 of the 29 patients had a second or a third hot phase. During the repeated hot phases, all 22 patients required readmission and showed frequent ischemic episodes of ST segment changes recorded on ambulatory ECG monitoring or rest 12-lead ECG monitoring in hospital. Of the remaining seven patients who did not experience a repeated hot phase but had regular vasospastic anginal attacks, three showed ST segment elevation during an exercise test early in the morning, and four had ST segment elevation on Holter monitoring out of hospital during follow-up.
Angiographic procedure. The present study was approved by the hospital ethics committee, and written informed consent was obtained from each patient. All patients were admitted to the coronary care unit before the study. Sublingual nitroglycerin was administered as required, but calcium antagonists and oral nitrates were gradually tapered, and calcium antagonists were discontinued for 36 h and oral nitrates for 24 h before the study. Coronary angiography was performed in the morning (from 8:30 AM to 11 AM) by the Sones technique at Anjo Kosei Hospital in Japan. After baseline angiograms suitable for quantitative analysis of the right and left coronary arteries had been obtained, 0.2 mg of ergonovine maleate was administered intravenously by a rapid bolus injection. Radiographic projections were identical during the sequential angiographic studies. Heart rate and aortic pressure were monitored continuously, and 12-lead ECGs were recorded at 30-s intervals. Whenever chest pain or significant ST segment changes were observed, selective coronary angiograms were immediately obtained. Coronary vasospasm was relieved by isosorbide dinitrate, given as one or two intracoronary boluses to a total of 5 rag. To exclude the possibility of persistent spasm, we gave a dose (5 mg) of intracoronary isosorbide dinitrate that was greater than the dose previously demonstrated (30,31) to achieve maximal coronary vasodilation in patients with vasospastic angina (3 rag). The follow-up angiogram was obtained in the same angiographic projection as the initial angiogram after viewing the initial angiographic records and cine film. Then, the response to ergonovine and the severity of fixed stenoses were quantified in the matched views of the initial and follow-up angiograms using the quantitative angiographic analysis system. No complications occurred during the repeated ergonovine provocation tests and the angiographic procedures.
Quantitative coronary angiographic analysis. The new version of the computer-based coronary angiography analysis system (CAAS II) (32,33) was used to perform the quantitative analysis in a core angiographic laboratory (Cardialysis, Rotterdam, The Netherlands). The CAAS analysis has been described in detail elsewhere (33) (34) (35) (36) (37) (38) (39) . Briefly, the entire cine frame of 18 x 24 mm is digitized at a resolution of 1,329 × 1,772 pixels. Correction for pin-cushion distortion is performed before analysis. Boundaries of a selected coronary segment are detected automatically. The absolute diameter of the stenosis in millimeters is determined using the guiding catheter as a scaling device (40) . To standardize the method of analysis of the initial and follow-up angiograms, all study frames selected for analysis were end-diastolic to minimize motion artifact, and arterial segments were measured between the same identifiable branch points at baseline, after administration of ergonovine and after administration of isosorbide dinitrate (41, 42) .
In the CAAS II system (32-42), minimal lumen diameter was determined by computer-based edge-detection contour using minimal cost criteria. The CAAS II system determines the size at the target coronary segment using a computerderived interpolated reference diameter rather than an operatorselected reference point. The interpolated reference diameter is derived from the edge-detection diameter function of the nonstenotic/nonspastic proximal and distal subsegments. The reference vessel diameter values are estimated by fitting a straight line to the diameter function proximal and distal to the obstruction followed by a shift such that 80% of the diameter values are below the adjusted straight line. This line then represents the reconstructed reference diameter function and gives an estimate of the arterial size at each point along the analyzed coronary segment. The interpolated reference vessel diameter is taken as the value of the reconstructed diameter function at the position of the minimal lumen diameter. The advantages of this approach are that it is essentially user independent, and thus highly reproducible, and that every measurement is based on multiple measurements (every scan line) proximal and distal to the lesion.
Segments analyzed. The coronary segments were coded according to the recommendations of the American Heart Association (AHA) (43) . One AHA segment from each of the three major epicardial vessels was analyzed. For vessels that demonstrated vasospasticity, the segment in which vasospasm occurred was analyzed. For vessels in which no vasospasm occurred, the AHA segment analyzed was that which had the most diseased appearance. Quantitative angiographic analysis provided the minimal lumen and reference vessel diameters for all AHA segments analyzed. Statistical analysis. The unpaired Student t test was used to compare the two groups of patients. Differences between proportions were analyzed by the cfii-square test with correction; p < 0.05 was considered significant.
Results
Clinical characteristics. All patients demonstrated persistent symptoms of vasospastic angina with ischemic ST segment changes during follow-up that were detected by in-hospital 12-lead or ambulatory ECG monitoring, or both, or Holter monitoring out of hospital. Medication was a combination of a calcium antagonist (diltiazem) and sustained-release isosorbide dinitrate. Although the medication reduced the frequency of ischemic attacks, symptoms of variant angina persisted throughout the follow-up period.
The ECG and angiographic results for all 29 patients are presented in Table 1 . The location of myocardial ischemia indicated by ECG changes and the spastic coronary segment shown by angiography were similar at the initial and follow-up tests in 13 patients (group 1, Patients 1 to 13) but were different at follow-up in 16 (group 2, Patients 14 to 29). With regard to clinical characteristics, no significant differences were found between groups 1 and 2 for age (56 _+ 7 vs. 54 _+ 9 years); gender (1 of 13 vs. 2 of 16 female patients); coronary risk factors, such as hypertension, diabetes, smoking and hypercholesterolemia; and average serum cholesterol level ( Table 2) . The mean interval to angiographic follow-up (46 + 15 vs. 41 _+ 11 months) was similar in the two groups, and there was no significant difference in medication. Group 2. Coronary spasm was observed in 23 segments at initial angiography ( Fig. 2A) . At follow-up, 13 of the 23 segments showed persistent vasospastic activity, but the remaining 10 segments showed no vasospasm. The minimal lumen and reference diameter changes for the remaining 25 segments of 25 vessels in group 2 are shown in Figure 2B . No spasm was observed at the initial test in these 25 segments, but at follow-up, 12 of the 25 exhibited vasospasm after ergonovine, and 13 had no vasospasm. An example of angiographic evidence of fluctuation in vasospastic location between initial and follow-up angiography in a patient in group 2 is shown in Figure 3 .
Discussion
Quantitative coronary angiography and repeated ergonovine provocation tests demonstrated that in some patients with persistent variant angina, spasm may fluctuate from one vessel to another over a period of several years, whereas in others the location of coronary spasm is fixed over time.
Previous studies. Although several studies have reported the spontaneous remission of vasospastic angina (14-17), persistence of symptoms of variant angina has been reported in other studies with long-term follow-up of up to 10 years (17) (18) (19) (20) . Although Kaski et al. (21) recently reported the consistency of angiographic location of vasospasm in 10 patients with variant angina despite medical therapy, conflicting and indirect evidence from previous ECG studies (14, 22, 23) suggests that the location and degree of coronary spasm may not be fixed. In a nonquantitative coronary angiographic study (18) , we previously showed that percent diameter stenosis as assessed visually may fluctuate over time, although the relation of such relative measures to atherosclerosis was not explored. Waters et al. (14) reported that the location of myocardial ischemia indicated by ST segment changes at follow-up was similar to that at the initial ergonovine test. However, the direction of ST segment shifts (elevation or depression) changed in 3 of 10 patients who had repeated vasospastic attacks at follow-up. Previtali et al. (23) reported that difference of location of myocardial ischemia as determined by ST segment changes was observed in a single patient, yet the dose of ergonovine required to induce vasospasm was different at follow-up in the majority of patients. Whittle et al. (22) reported that variable and unpredictable ECG responses to repeated ergonovine tests were observed in 6 of 10 patients, whereas the remaining 4 exhibited reproducible ECG responses to ergonovine. Our quantitative coronary angiographic study clearly demonstrated that the location of coronary spasm was variable in some patients with persistent symptoms of angina. The variability of ECG changes seen during recurrent vasospastic angina attacks may be due to these phenomena. It has been proposed that the parasympathetic nervous system may play a role in the pathogenesis of variant angina (44) , and variation in autonomic tone may therefore contribute to fluctuations in vasospastic behavior. Recent experimental studies (45) (46) (47) (48) (49) (50) demonstrate that several endothelium-derived factors mediate vascular smooth muscle tone and that damaged endothelium may play a major role in the pathogenesis of vasospasm. Endothelial damage may occur even in the early stages of atherosclerosis (48) (49) (50) . Zeiher et al. (51) indicated that abnormal vasoconstriction was observed in early atherosclerotic sites in patients without variant angina, using intracorona~ ultrasound. Yamagishi et al. (52) reported that early stages of atherosclerosis were observed by intracoronary ultra~und at the site of spasm in patients with variant angina.
In our study, although the minimal lumen diameter of fixed stenosis tended to be smaller at follow-up than at the initial angiogram in 9 of 12 new spastic segments, in 8 of 10 previous spastic segments the minimal lumen diameter of fixed stenosis tended to be larger at follow-up. Both Waters et al. (53) and our group (54) recently reported that the standard deviation of repeated quantitative measurements with the CAAS system of serial clinical coronary angiograms is _+0,20 ram, and a difference greater than twice the standard deviation for repeated measurements of the CAAS system may represent a true change with >95% confidence. If we adopt a per-lesion categoric approach to the definition of progression or regres-sion of atherosclerosis, we would include only lesions with a change >0.40 mm at follow-up. If such a categoric approach were applied, then a significant progression occurred in group 2 with 95% confidence in 2 of 12 new spastic segments, and significant regression was not seen in any new spastic segments (0 of 12). Significant progression of fixed atherosclerosis was not observed in any previously spastic segments in which spastic activity was no longer provoked (0 of 10), and significant regression was seen in 2 of 10 previous spastic segments. If a continuous statistical approach is adopted in which the mean change in minimal lumen diameter is analyzed for the study group, we find that in Group 2 the minimal lumen diameter after administration of isosorbide dinitrate at new spastic segments was significantly smaller at follow-up than that at initial angiography (2.44 m 0.32 mm initially vs. 2.29 +_ 0.30 mm at follow-up, p < 0.05). However, the minimal lumen diameter in previous spastic segments, which demonstrated vasospasm at initial angiography but not at follow-up, was significantly larger at follow-up than at initial angiography (2.24 _+ 0.51 mm initially vs. 2.40 _+ 0.42 mm at follow-up, p < 0.05). Thus, if a continuous statistical approach is adopted for each study cohort, we observe that the development of spasm at a new site is associated with a reduction, and the disappearance of spasm with an improvement, in minimal lumen diameter after isosorbide dinitrate.
The present data lend support to the concept that fluctuation of spastic locations might relate to the pathologic process of local progression and regression of early atherosclerosis in coronary arteries. Clearly, a large prospective (and probably multicenter) trial with long-term angiographic follow-up and repeated ergonovine testing would be required to definitively establish this point.
Conclusions. Quantitative coronary angiography and repeated ergonovine provocation tests demonstrate that in some patients with persistent variant angina, spasm may fluctuate from one vessel to another over a period of several years, whereas in others the location of coronary spasm is fixed over time. Vasospastic angina may not only be a transient disease restricted in location, but may also be a persistent and variable condition involving multiple vessels over many years.
